CDC is pulling back $11B in Covid funding sent to health departments across the U.S.

CDC is pulling back B in Covid funding sent to health departments across the U.S.


A general view of the Centers for Disease Control and Prevention (CDC) headquarters in Atlanta, Georgia.

Tami Chappell | Reuters

The Centers for Disease Control and Prevention is pulling back $11.4 billion in funds allocated in response to the pandemic to state and community health departments, nongovernment organizations and international recipients, the Department of Health and Human Services confirmed Tuesday.

“The COVID-19 pandemic is over, and HHS will no longer waste billions of taxpayer dollars responding to a non-existent pandemic that Americans moved on from years ago,” HHS Director of Communications Andrew Nixon said in a statement. “HHS is prioritizing funding projects that will deliver on President Trump’s mandate to address our chronic disease epidemic and Make America Healthy Again.

HHS oversees 13 agencies, including CDC, which is tasked with protecting the nation’s health. Notices began going out Monday and awardees have 30 days to reconcile their expenditures. Figures are subject to change.

The funding slash comes on the heels of other cuts under new Health and Human Services Secretary Robert F. Kennedy Jr., including the canceling of hundreds of millions of dollars in grants for research into vaccine hesitancy, LGBTQ populations and supporting HIV prevention.

“Now that the pandemic is over, the grants and cooperative agreements are no longer necessary as their limited purpose has run out,” read notices of termination sent to grantees on Monday and shared with NBC News.

The federal public health emergency ended May 11, 2023, but more than 1.2 million Americans have died from Covid according to the CDC. Though infection has slowed and the disease has become milder, hundreds of people still die every week from Covid, and long Covid symptoms continue to cause debilitating medical problems in some cases. 

The clawed-back funds were largely being used for Covid testing, vaccination, community health workers and initiatives to address Covid health disparities among high-risk and underserved populations, including racial and ethnic minority populations and rural communities, as well as global Covid projects, according to talking points emailed from CDC leadership to agency departments on Tuesday.

CDC reviewed a list of HHS-provided Covid grants and cooperative agreements and identified the programs that were no longer needed, according to the talking points.

A list of projects for the rescinded funds was not immediately available. Greg Flynn, media relations director for the Mississippi State Department of Health, confirmed the state had received notice of the funding decision and was “currently working to assess the potential impacts to our agency.”

Charla Haley, public information officer for Utah’s Department of Health, said in an email, “We are currently evaluating impact.”

So far, HHS has made the deepest budget cuts government-wide under the Trump administration’s efforts to radically slash federal funding, according to a tally listed on The Department of Government Efficiency’s website.

HHS also canceled $877 million in grants to the Texas Department of Health and $482 million to Florida’s health department among other cuts this week, according to DOGE’s website. 



Source

Eli Lilly hikes 2025 outlook, tops quarterly estimates as Mounjaro, Zepbound sales soar
Health

Eli Lilly hikes 2025 outlook, tops quarterly estimates as Mounjaro, Zepbound sales soar

The Eli Lilly logo is shown on one of the company’s offices in San Diego, California, on Sept. 17, 2020. Mike Blake | Reuters Eli Lilly on Thursday hiked its 2025 guidance and posted second-quarter earnings that topped estimates on strong demand for its blockbuster weight loss and diabetes drugs. The company raised its fiscal 2025 […]

Read More
Eli Lilly’s obesity pill led to around 12% weight loss in closely watched late-stage trial, paving way for approval
Health

Eli Lilly’s obesity pill led to around 12% weight loss in closely watched late-stage trial, paving way for approval

A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024. Scott Olson | Getty Images Eli Lilly on Thursday said the highest dose of its daily obesity pill helped patients lose almost 12% of their body weight, or roughly 27 pounds, at 72 weeks in […]

Read More
Eli Lilly earnings are coming Thursday. Here’s what top analysts expect
Health

Eli Lilly earnings are coming Thursday. Here’s what top analysts expect

Many on Wall Street expect that Novo Nordisk ‘s loss has been Eli Lilly ‘s gain, and this will be good news for the Zepbound maker’s second-quarter results. Novo Nordisk’s stock has cratered about 47% since the start of the year, as doubts emerged about the outlook for its GLP-1 drugs, Ozempic for diabetes and […]

Read More